A multi-center clinical trial evaluating the safety and effectiveness of two different candidate microbicides, BufferGel® and PRO 2000, in 3,100 sexually active HIV-negative women at seven sites in Africa and the United States. Results have been reported. (See news release below.)
See
Dec 14, 2009
Dec 14, 2009
Feb 9, 2009
See Also
Feb 9, 2009
Watch
Feb 9, 2009
